Search of: "Thalidomide" - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 236 studies with search of:

"Thalidomide"

Hide studies that are not seeking new volunteers.

Display Options

1	Terminated	Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
		Condition:	Newly Diagnosed, Multiple Myeloma
		Interventions:	Drug: Thalidomide; Drug: melphalan, prednisone; Drug: melphalan, prednisone, thalidomide

2	Completed	Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
		Condition:	Multiple Myeloma
		Intervention:	Drug: Thalidomide

3	Completed	Thalidomide to Patients With Previously Untreated Multiple Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: thalidomide; Drug: placebo

4	Recruiting	Thalidomide in Pediatric Inflammatory Bowel Diseases.
		Conditions:	Inflammatory Bowel Diseases; Crohn's Disease; Ulcerative Colitis
		Interventions:	Drug: Thalidomide; Drug: placebo

5	Recruiting	A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC)in Newly Diagnosed Multiple Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: bortezomib, dexamethasone, and thalidomide; Drug: bortezomib, dexamethasone, thalidomide, and cyclophosphamide

6	Recruiting	Thalidomide and Temozolomide or CPT-11 in Patients With Gliomas
		Conditions:	Glioblastoma Multiforme; Glioma
		Interventions:	Drug: Thalidomide; Drug: CPT-11

7	Recruiting	GEM05 for Patients With Multiple Myeloma Under 65 Years
		Condition:	Multiple Myeloma
		Interventions:	Drug: VBMCP/VBAD/Velcade; Drug: Thalidomide/Dexamethasone; Drug: Velcade/Thalidomide/Dexamethasone

8	Terminated	Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
		Condition:	Prostatic Neoplasms
		Interventions:	Drug: GM-CSF; Drug: thalidomide; Drug: docetaxel

9	Recruiting	Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis
		Conditions:	Graft vs Host Disease; Stomatitis; Bone Marrow Transplantation
		Interventions:	Drug: Thalidomide; Drug: Thalidomide Gel

10	Recruiting	Thalidomide/Dexamethasone Vs MP for Induction Therapy and Thalidomide/Intron A Vs Intron A for Maintenance Therapy
		Condition:	Multiple Myeloma
		Intervention:	Drug: Thalidomide/Dexamethasone vs Melphalan/Prednisone

11	Terminated	Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
		Condition:	Scleroderma, Systemic
		Interventions:	Drug: Thalidomide; Drug: Placebo thalidomide

12	Recruiting	Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: Bortezomib; Drug: Thalidomide

13	Active, not recruiting	Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD.
		Condition:	Multiple Myeloma
		Interventions:	Drug: thalidomide and dexamethasone; Drug: vincristine and adriamycin and dexamethasone; Drug: doxorubicin; Drug: zoledronic acid

14	Recruiting	Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
		Conditions:	Hepatocellular Carcinoma; Liver Cancer
		Intervention:	Drug: thalidomide

15	Active, not recruiting	Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
		Condition:	Multiple Myeloma
		Interventions:	Drug: Pamidronate; Drug: Thalidomide; Drug: Zometa

16	Not yet recruiting	Study to Determine Efficacy and Safety of Lenalidomide Plus Low-Dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: Lenalidomide and low-dose dexamethasone; Drug: Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles; Drug: Melphalan, Prednisone and Thalidomide

17	Completed	Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
		Condition:	Multiple Myeloma
		Interventions:	Drug: thalidomide; Drug: interferon alpha

18	Not yet recruiting	Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
		Condition:	Myelodysplastic Syndrome
		Intervention:	Drug: 5-aza-cytidine and Thalidomide

19	Recruiting	Thalidomide in MALT Lymphoma Patients
		Condition:	MALT Lymphoma
		Intervention:	Drug: Thalidomide, Pharmion

20	Active, not recruiting	SARCOTHAL. Thalidomide in Skin Sarcoidosis
		Condition:	Sarcoidosis
		Intervention:	Drug: THALIDOMIDE

21	Active, not recruiting	Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: dexamethasone; Drug: thalidomide; Drug: lenalidomide

22	Active, not recruiting	Thalidomide + Dexamethasone vs. DOXIL (Doxorubicin HCl Liposome Injection) + Thalidomide + Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
		Conditions:	Multiple Myeloma; Cancer
		Intervention:	Drug: DOXIL (doxorubicin HCl liposome injection) + Thalidomide + Dexamethasone

23	Recruiting	Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: Bortezomib; Drug: Thalidomide

24	Active, not recruiting	Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall
		Condition:	Sarcoma
		Interventions:	Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: filgrastim; Drug: ifosfamide; Drug: thalidomide; Procedure: adjuvant therapy; Procedure: conventional surgery; Procedure: neoadjuvant therapy; Procedure: radiation therapy

25	Active, not recruiting	Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
		Conditions:	Waldenstrom's Macroglobulinemia; Lymphoplasmacytic Lymphoma
		Interventions:	Drug: Thalidomide; Drug: Rituximab

26	Completed	Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200
		Condition:	Myelodysplastic Syndromes
		Intervention:	Drug: Thalidomide

27	Terminated	Use of Thalidomide in Chronic Uveitis
		Condition:	Uveitis
		Intervention:	Drug: Thalidomide

28	Completed	Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
		Conditions:	HIV Infections; Stomatitis, Aphthous
		Intervention:	Drug: Thalidomide

29	Recruiting	The Effects of Thalidomide on Symptom Clusters
		Condition:	Advanced Cancers
		Interventions:	Drug: Thalidomide; Drug: Placebo

30	Completed	Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors
		Condition:	Neuroendocrine Tumor
		Interventions:	Drug: Thalidomide; Drug: Temodar

31	Completed	Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
		Condition:	Leukemia
		Intervention:	Drug: Thalidomide

32	Completed	Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
		Condition:	Multiple Myeloma
		Interventions:	Drug: Pamidronate; Drug: Thalidomide

33	Recruiting	Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma
		Condition:	Hepatocellular Carcinoma
		Intervention:	Drug: Thalidomide

34	Completed	Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
		Condition:	Colorectal Adenocarcinoma
		Interventions:	Drug: Capecitabine; Drug: Thalidomide

35	Recruiting	UFUR Plus Thalidomide for Advanced Hepatocelllular Carcinoma
		Condition:	Hepatocellular Carcinoma
		Interventions:	Drug: Thalidomide; Drug: Tegafur/Uracil

36	Completed	Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
		Condition:	Multiple Myeloma
		Intervention:	Drug: Thalidomide

37	Completed	Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
		Conditions:	HIV Infections; HIV Wasting Syndrome
		Intervention:	Drug: Thalidomide

38	Active, not recruiting	Study of Combination PS-341 and Thalidomide in Multiple Myeloma
		Condition:	Multiple Myeloma
		Interventions:	Drug: PS-341; Drug: Thalidomide; Drug: Dexamethasone

39	Recruiting	Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
		Conditions:	Brain Neoplasms; Melanoma
		Interventions:	Drug: Lomustine; Drug: Temozolomide; Drug: Thalidomide

40	Completed	Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients
		Condition:	HIV Infections
		Intervention:	Drug: Thalidomide

41	Completed	Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom’s Macroglobulinemia
		Condition:	Waldenstrom Macroglobulinemia
		Intervention:	Drug: Thalidomide

42	Completed	A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
		Condition:	HIV Infections
		Intervention:	Drug: Thalidomide

43	Recruiting	Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
		Condition:	Multiple Myeloma
		Interventions:	Drug: Thalidomide; Drug: Defibrotide; Drug: Alkeran; Drug: Prednisone

44	Completed	Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
		Condition:	Multiple Myeloma
		Interventions:	Drug: Thalidomide; Drug: Dexamethasone

45	Completed	DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
		Condition:	Multiple Myeloma
		Interventions:	Drug: Thalidomide; Drug: Dexamethasone; Drug: Cytoxan; Drug: Etoposide; Drug: Cisplatin; Drug: G-CSF

46	Completed	A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
		Condition:	Neoplasms
		Interventions:	Drug: Thalidomide; Drug: Celecoxib; Drug: Etoposide; Drug: Cyclophosphamide

47	Completed	Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
		Condition:	Multiple Myeloma
		Intervention:	Drug: Thalidomide

48	Completed	Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
		Conditions:	Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection
		Intervention:	Drug: Thalidomide

49	Active, not recruiting	Total Therapy II: Study for Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
		Condition:	Multiple Myeloma
		Interventions:	Drug: Thalidomide; Drug: Ara-C; Drug: BCNU; Drug: Cisplatin; Drug: Cytoxan; Drug: Dexamethasone; Drug: Doxorubicin; Drug: Etoposide; Drug: Filgrastim; Drug: Recombinant GM-CSF; Drug: Interferon-alpha-2b; Drug: Melphalan; Drug: Vincristine

50	Completed	A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
		Condition:	HIV Infections
		Intervention:	Drug: Thalidomide

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options